MedPath
HSA Product

PLAQUENIL TABLET 200 mg (White)

Product approved by Health Sciences Authority (SG)

Basic Information

PLAQUENIL TABLET 200 mg (White)

TABLET, FILM COATED

Regulatory Information

SIN12213P

February 28, 2003

Prescription Only

Therapeutic

ORAL

August 10, 2023

May 30, 2025

Company Information

SANOFI AVENTIS, SA

SANOFI-AVENTIS SINGAPORE PTE. LTD.

SANOFI-AVENTIS SINGAPORE PTE. LTD.

Active Ingredients

HYDROXYCHLOROQUINE SULPHATE

Strength: 200.0 mg

Detailed Information

Contraindications

**4.3 Contraindications** - Known hypersensitivity to 4-aminoquinoline compounds - Pre-existing maculopathy of the eye - Below 6 years of age (200 mg tablets not adapted for weight <35 kg) or for ideal body weight < 31 kg (see section 4.2)

Indication Information

**4.1 Therapeutic Indications** Treatment of rheumatoid arthritis, juvenile chronic arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight.

© Copyright 2025. All Rights Reserved by MedPath